A cell membrane like biomimetic drug-eluting coronary stent

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 13, Issue 21, 2009, Pages 4109-4112

  Fan, De Zeng ^a   Yah, Xin Hao ^a   Bian, Hui Juan ^a   Cai, Chen Shui ^a   Sun, Fu Yu ^a   Ji, Jian ^b   Xu, Jian Ping ^b   Jin, Qiao ^b   Shen, Jia Cong ^b   Qiu, Hong ^c   Gao, Run Lin ^c  

^a CENTRAL IRON AND STEEL RESEARCH INSTITUTE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (TRIMETHOXYSILYL)PROPYLMETHACRYLATE; BETA HYDROXYPROPYL METHACRYLATE; BIOMIMETIC MATERIAL; COPOLYMER; FREE RADICAL; METAL; METHACRYLIC ACID; PHENOBARBITAL; PHOSPHOLIPID; RAPAMYCIN; STEARYL METHACRYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; BIOMIMETICS; BLOOD VESSEL DIAMETER; CELL MEMBRANE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELUTING STENT; DRUG RELEASE; DRUG SAFETY; NONHUMAN; POLYMERIZATION; RESTENOSIS; SWINE;

ANIMALIA; SUIDAE; SUS;

EID: 67649972431     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-8225.2009.21.025     Document Type: Article

References (24)

1. Hoffmann R, Mintz GS, Popma JJ, et al. Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. J Am Coll Cardiol. 1996;28(5):1134-1349. (Pubitemid 26376985)
2. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701-706. (Pubitemid 17036474)
3. Hu YG, Zhang HJ, Yang YJ. Biocompatibility and clinical application of coronary stents Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2008;12(17):3297-3300.
4. Li XF, Xu J, You L, Gao FM. Endovascular stent, coronary stent and drug eluting stent. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2008;12(26):5123-5126.
5. Ding MH, Li L, Zheng YF. Research progress in drug-loaded Materials of drug eluting stents and their preparation technology. Cailiao Daobao. 2007;21(10):39-42.
6. Zwaal RF, Comfurius P, van Deenen LL. Membrane asymmetry and blood coagulation. Nature. 1977;268(5618):358-360. (Pubitemid 8142006)
7. Kandzari DE, Leon MB, Popma JJ, et al. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol. 2006;48(12):2440-2447. (Pubitemid 44881222)
8. Sakurai R, Hongo Y, Yamasaki M, et al. Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol. 2007;100(5):818-823.
9. Kandzari DE, Leon MB. Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent. J Interv Cardiol. 2006;19(5):405-413. (Pubitemid 44511071)
10. Luo J, Wang L, Chen Y, et al. The hydrpphilicity and cell affinity of polylactic acid containg bionic function group of phosphorylcholine. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2008;25(6):1344-1348.
11. Wachiralarpphaithoon C, Iwasaki Y, Akiyoshi K. Enzyme-degradable phosphorylcholine porous hydrogels cross-linked with polyphosphoesters for cell matrices. Biomaterials. 2007;28(6):984-993. (Pubitemid 44809430)
12. Kyomoto M, Iwasaki Y, Moro T, et al. High lubricious surface of cobalt-chromium-molybdenum alloy prepared by grafting poly(2- methacryloyloxyethyl phosphorylcholine). Biomaterials. 2007;28(20):3121-3130. (Pubitemid 46602518)
13. Nam K, Kimura T, Kishida A. Preparation and characterization of cross-linked collagen-phospholipid polymer hybrid gels. Biomaterials. 2007;28(1):1-8. (Pubitemid 44427898)
14. Kimura M, Fukumoto K, Watanabe J, et al. Spontaneously forming hydrogel from water-soluble random- and block-type phospholipid polymers. Biomaterials. 2005;26(34):6853-6862. (Pubitemid 41102147)
15. Gershlick A, Kandzari DE, Leon MB, et al. Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients. Am J Cardiol. 2007;100(8B):45-55M. (Pubitemid 47576036)
16. Garcia-Touchard A, Burke SE, Toner JL, et al. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks. Eur Heart J. 2006;27(8):988-993.
17. Hayward JA, Chapman D. Biomembrane surfaces as models for polymer design: the potential for haemocompatibility. Biomaterials. 1984;5(3):135-142. (Pubitemid 14116173)
18. Lewis AL. Phosphorylcholine-based polymers and their use in the prevention of biofouling. Colloids Surf B Biointerfaces. 2000;18(3-4):261-275. (Pubitemid 30479867)
19. Wang DA, Ji J, Gao CY, et al. Surface coating of stearyl poly(ethylene oxide) coupling-polymer on polyurethane guiding catheters with poly(ether urethane) film-building additive for biomedical applications. Biomaterials. 2001;22(12):1549-1562. (Pubitemid 32551904)
20. The Ministry of Science and Technology of People's Republic of China. Regulations for the Administration of Affairs Concerning Experimental Animals.1988-2010-31.
21. Takahara A, Jo NJ, Kajiyama T. Surface molecular mobility and platelet reactivity of segmented poly(etherurethaneureas) with hydrophilic and hydrophobic soft segment components. J Biomater Sci Polym Ed. 1989;1(1):17-29.
22. Lewis AL, Willis SL, Small SA, et al. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo. Biomed Mater Eng. 2004;14(4):355-370. (Pubitemid 40916709)
23. Rose SF, Lewis AL, Hanlon GW, et al. Biological responses to cationically charged phosphorylcholine-based materials in vitro. Biomaterials. 2004;25(21):5125-5135. (Pubitemid 38510398)
24. Anis RR, Karsch KR. The future of drug eluting stents. Heart. 2006;92(5):585-588.